First Sickle Cell Patient Treated with CRISPR Gene Editing is Now Thriving One Year Later, And Able to Care For Her Kids

First Sickle Cell Patient Treated with CRISPR Gene Editing is Now Thriving One Year Later, And Able to Care For Her Kids

The first patient to be treated for Sickle Cell Disease with the revolutionary gene-editing program CRISPER had a transfusion of billions of modified cells last year, and now a year later her treatment is still working perfectly. Before Victoria Gray underwent the treatment in mid-2019 she had been experiencing frequent … Read more